Literature DB >> 17106493

The war on cancer: a report from the front lines.

Gavin Melmed1.   

Abstract

Entities:  

Year:  2006        PMID： 17106493      PMCID： PMC1618753          DOI： 10.1080/08998280.2006.11928194

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  166 in total

1.  The Nobel chronicles. 1979: Allan MacLeod Cormack (b 1924); and Sir Godfrey Newbold Hounsfield (b 1919).

Authors:  T N Raju
Journal:  Lancet       Date:  1999-11-06       Impact factor: 79.321

Review 2.  Interferon in metastatic renal cell carcinoma.

Authors:  S D Fosså
Journal:  Semin Oncol       Date:  2000-04       Impact factor: 4.929

3.  The polymerase chain reaction. History, methods, and applications.

Authors:  N S Templeton
Journal:  Diagn Mol Pathol       Date:  1992-03

4.  Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan/cyclophosphamide vs total body irradiation: a meta-analysis.

Authors:  A R Hartman; S F Williams; J J Dillon
Journal:  Bone Marrow Transplant       Date:  1998-09       Impact factor: 5.483

Review 5.  Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients. A systematic review of the literature with meta-analysis.

Authors:  T Berghmans; M Paesmans; J J Lafitte; C Mascaux; A P Meert; C Jacquy; A Burniat; E Steels; F Vallot; J P Sculier
Journal:  Support Care Cancer       Date:  2001-11-23       Impact factor: 3.603

6.  International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.

Authors: 
Journal:  J Clin Oncol       Date:  1997-02       Impact factor: 44.544

7.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

Review 8.  Transfusion-associated graft-versus-host disease and the irradiation of blood components.

Authors:  R J Davey
Journal:  Immunol Invest       Date:  1995 Jan-Feb       Impact factor: 3.657

9.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

10.  Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2.

Authors:  S A Rosenberg; J C Yang; S L Topalian; D J Schwartzentruber; J S Weber; D R Parkinson; C A Seipp; J H Einhorn; D E White
Journal:  JAMA       Date:  1994 Mar 23-30       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.